Discordance between CD4 cell count and percentage associated with markers of liver disease in HIV/hepatitis C co-infected people
Liver fibrosis increases risk of discordance in CD4 cell count and percentage in HIV-positive people
Hepatitis C infection now twice as common in HIV+ gay men as injecting drug users, Swiss study finds
Full speed ahead to curing hepatitis C
Antiretroviral rollout provides a model for efforts to expand hepatitis C treatment and care in resource-limited settings
Studies look at interactions between new hepatitis C drugs and HIV antiretrovirals
GS-7977 plus ribavirin rapidly suppresses HCV but most patients relapse
Telaprevir and boceprevir boost sustained response rates for HIV/HCV coinfected
